Oncolytics Biotech Inc. (ONC.TO)
CAD 1.1
(-2.65%)
CAD 1.1
(-2.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 33.79 Million CAD | 25.51% |
| 2022 | 26.92 Million CAD | 2.63% |
| 2021 | 26.23 Million CAD | 3.05% |
| 2020 | 25.45 Million CAD | 23.03% |
| 2019 | 20.69 Million CAD | 24.19% |
| 2018 | 16.66 Million CAD | 6.77% |
| 2017 | 15.6 Million CAD | 2.03% |
| 2016 | 15.29 Million CAD | 9.89% |
| 2015 | 13.91 Million CAD | -26.06% |
| 2014 | 18.82 Million CAD | -21.24% |
| 2013 | 23.89 Million CAD | -34.86% |
| 2012 | 36.68 Million CAD | 27.74% |
| 2011 | 28.72 Million CAD | 85.23% |
| 2010 | 15.5 Million CAD | -8.81% |
| 2009 | 17 Million CAD | 23.59% |
| 2008 | 13.75 Million CAD | -18.33% |
| 2007 | 16.84 Million CAD | 8.71% |
| 2006 | 15.49 Million CAD | 16.39% |
| 2005 | 13.31 Million CAD | -0.14% |
| 2004 | 13.33 Million CAD | 92.34% |
| 2003 | 6.93 Million CAD | -0.41% |
| 2002 | 6.96 Million CAD | -2.48% |
| 2001 | 7.13 Million CAD | 44.02% |
| 2000 | 4.95 Million CAD | 758.31% |
| 1999 | 577.37 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 7.82 Million CAD | -7.94% |
| 2024 Q1 | 8.6 Million CAD | -1.59% |
| 2023 FY | 33.38 Million CAD | 24.01% |
| 2023 Q1 | 6.73 Million CAD | -20.85% |
| 2023 Q2 | 7.16 Million CAD | 6.33% |
| 2023 Q4 | 8.74 Million CAD | -20.87% |
| 2023 Q3 | 11.04 Million CAD | 54.3% |
| 2022 Q4 | 8.5 Million CAD | 40.4% |
| 2022 Q3 | 6.05 Million CAD | 0.23% |
| 2022 FY | 26.92 Million CAD | 2.63% |
| 2022 Q1 | 6.31 Million CAD | -15.36% |
| 2022 Q2 | 6.04 Million CAD | -4.18% |
| 2021 Q1 | 5.9 Million CAD | -26.9% |
| 2021 FY | 26.23 Million CAD | 3.05% |
| 2021 Q4 | 7.45 Million CAD | 21.12% |
| 2021 Q3 | 6.15 Million CAD | -8.46% |
| 2021 Q2 | 6.72 Million CAD | 13.95% |
| 2020 FY | 25.45 Million CAD | 23.03% |
| 2020 Q4 | 8.07 Million CAD | 27.81% |
| 2020 Q3 | 6.31 Million CAD | 13.85% |
| 2020 Q2 | 5.54 Million CAD | 0.45% |
| 2020 Q1 | 5.52 Million CAD | -20.45% |
| 2019 Q1 | 4.98 Million CAD | 2.16% |
| 2019 FY | 20.69 Million CAD | 24.19% |
| 2019 Q4 | 6.94 Million CAD | 101.13% |
| 2019 Q3 | 3.45 Million CAD | -34.98% |
| 2019 Q2 | 5.3 Million CAD | 6.42% |
| 2018 Q2 | 3.68 Million CAD | -21.57% |
| 2018 Q3 | 3.39 Million CAD | -7.78% |
| 2018 FY | 16.66 Million CAD | 6.77% |
| 2018 Q4 | 4.88 Million CAD | 43.73% |
| 2018 Q1 | 4.69 Million CAD | 1.29% |
| 2017 FY | 15.6 Million CAD | 2.03% |
| 2017 Q4 | 4.63 Million CAD | 52.73% |
| 2017 Q3 | 3.03 Million CAD | -30.41% |
| 2017 Q2 | 4.36 Million CAD | 22.27% |
| 2017 Q1 | 3.56 Million CAD | -31.74% |
| 2016 Q3 | 3.36 Million CAD | 28.58% |
| 2016 Q1 | 4.08 Million CAD | 15.6% |
| 2016 FY | 15.29 Million CAD | 9.89% |
| 2016 Q4 | 5.22 Million CAD | 55.38% |
| 2016 Q2 | 2.61 Million CAD | -35.97% |
| 2015 Q4 | 3.53 Million CAD | 22.71% |
| 2015 Q2 | 3.89 Million CAD | 7.91% |
| 2015 Q1 | 3.6 Million CAD | -5.33% |
| 2015 FY | 13.91 Million CAD | -26.06% |
| 2015 Q3 | 2.88 Million CAD | -26.01% |
| 2014 Q3 | 4.67 Million CAD | -1.84% |
| 2014 Q1 | 5.56 Million CAD | -5.08% |
| 2014 Q4 | 3.81 Million CAD | -18.51% |
| 2014 Q2 | 4.76 Million CAD | -14.45% |
| 2014 FY | 18.82 Million CAD | -21.24% |
| 2013 Q2 | 5.12 Million CAD | -23.3% |
| 2013 FY | 23.89 Million CAD | -34.86% |
| 2013 Q4 | 5.86 Million CAD | -5.73% |
| 2013 Q3 | 6.22 Million CAD | 21.45% |
| 2013 Q1 | 6.68 Million CAD | -21.66% |
| 2012 Q1 | 8.57 Million CAD | 37.7% |
| 2012 Q2 | 10.27 Million CAD | 19.78% |
| 2012 FY | 36.68 Million CAD | 27.74% |
| 2012 Q3 | 9.3 Million CAD | -9.45% |
| 2012 Q4 | 8.52 Million CAD | -8.33% |
| 2011 Q3 | 6.33 Million CAD | -3.32% |
| 2011 FY | 28.72 Million CAD | 85.23% |
| 2011 Q1 | 4.09 Million CAD | 23.69% |
| 2011 Q2 | 6.55 Million CAD | 59.85% |
| 2011 Q4 | 6.22 Million CAD | -1.65% |
| 2010 Q4 | 3.31 Million CAD | -17.71% |
| 2010 Q3 | 4.02 Million CAD | -7.67% |
| 2010 Q2 | 4.36 Million CAD | 5.06% |
| 2010 FY | 15.5 Million CAD | -8.81% |
| 2010 Q1 | 4.15 Million CAD | 187.15% |
| 2009 Q3 | 2.69 Million CAD | -37.83% |
| 2009 FY | 17 Million CAD | 23.59% |
| 2009 Q1 | 3.97 Million CAD | 702.75% |
| 2009 Q2 | 4.33 Million CAD | 9.15% |
| 2009 Q4 | 1.44 Million CAD | -46.41% |
| 2008 Q4 | 495.14 Thousand CAD | -88.24% |
| 2008 FY | 13.75 Million CAD | -18.33% |
| 2008 Q1 | 3.49 Million CAD | -19.54% |
| 2008 Q2 | 5.48 Million CAD | 56.98% |
| 2008 Q3 | 4.21 Million CAD | -23.27% |
| 2007 Q2 | 4.04 Million CAD | 16.34% |
| 2007 FY | 16.84 Million CAD | 8.71% |
| 2007 Q4 | 4.34 Million CAD | 6.89% |
| 2007 Q3 | 4.06 Million CAD | 0.37% |
| 2007 Q1 | 3.48 Million CAD | -32.27% |
| 2006 FY | 15.49 Million CAD | 16.39% |
| 2006 Q3 | 3.74 Million CAD | 12.66% |
| 2006 Q2 | 3.32 Million CAD | 52.38% |
| 2006 Q4 | 5.13 Million CAD | 37.38% |
| 2006 Q1 | 2.17 Million CAD | -14.52% |
| 2005 Q1 | 2.6 Million CAD | -37.85% |
| 2005 Q2 | 3.03 Million CAD | 16.61% |
| 2005 FY | 13.31 Million CAD | -0.14% |
| 2005 Q3 | 4.2 Million CAD | 38.51% |
| 2005 Q4 | 2.54 Million CAD | -39.44% |
| 2004 Q1 | 2.84 Million CAD | 38.26% |
| 2004 Q4 | 4.19 Million CAD | 38.05% |
| 2004 Q2 | 3.37 Million CAD | 18.86% |
| 2004 Q3 | 3.03 Million CAD | -10.02% |
| 2004 FY | 13.33 Million CAD | 92.34% |
| 2003 Q1 | 1.15 Million CAD | -34.24% |
| 2003 FY | 6.93 Million CAD | -0.41% |
| 2003 Q4 | 2.05 Million CAD | 6.71% |
| 2003 Q3 | 1.92 Million CAD | 4.65% |
| 2003 Q2 | 1.83 Million CAD | 58.99% |
| 2002 Q1 | 1.49 Million CAD | -52.88% |
| 2002 FY | 6.96 Million CAD | -2.48% |
| 2002 Q4 | 1.75 Million CAD | -20.49% |
| 2002 Q3 | 2.21 Million CAD | 47.93% |
| 2002 Q2 | 1.49 Million CAD | 0.21% |
| 2001 FY | 7.13 Million CAD | 44.02% |
| 2001 Q2 | 1.02 Million CAD | 30.17% |
| 2001 Q3 | 2.16 Million CAD | 111.2% |
| 2001 Q1 | 785.9 Thousand CAD | -32.53% |
| 2001 Q4 | 3.16 Million CAD | 46.6% |
| 2000 Q1 | 408.99 Thousand CAD | 0.0% |
| 2000 Q2 | 1.54 Million CAD | 276.55% |
| 2000 Q3 | 1.84 Million CAD | 19.59% |
| 2000 Q4 | 1.16 Million CAD | -36.76% |
| 2000 FY | 4.95 Million CAD | 758.31% |
| 1999 FY | 577.37 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Appili Therapeutics Inc. | 8.83 Million CAD | -282.383% |
| Eupraxia Pharmaceuticals Inc. | 37.92 Million CAD | 10.898% |
| Helix BioPharma Corp. | 9.35 Million CAD | -261.131% |
| Microbix Biosystems Inc. | 10.21 Million CAD | -230.708% |
| Medicenna Therapeutics Corp. | 19.66 Million CAD | -71.851% |
| Satellos Bioscience Inc. | 6.64 Million CAD | -408.441% |
| Sernova Corp. | 41.13 Million CAD | 17.845% |